Pricing Supplement No. E516
To prospectus supplement dated April 26, 2024 and
prospectus dated April 26, 2024
Registration Statement No. 333-278331
Rule 424(b)(2)
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus supplement and prospectus do not constitute an offer to sell nor do they seek an offer to buy the notes in... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 14, 2026
Bowman Consulting Group Ltd.
(Exact name of registrant as specified in its charter)
Delaware 001-40371 54-1762351
(State or other jurisdiction
of incorporation)
More SEC Filings
View Older Stories-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form NPORT-P GLENMEDE FUND INC For: Jul 31
-
Form D Alexander Capital Ventur
-
Form 8-K Bowman Consulting Group For: Sep 14
-
Form 8-K Summit Therapeutics Inc. For: Sep 13
-
Form 8-K Cambium Networks Corp For: Sep 11
-
Form 8-K DeFi Development Corp. For: Sep 14
-
Form D Dine Bidziil, PBC
-
Form D SE-0904 Fund II, a serie
-
Form ARS TWIN DISC INC For: Jun 30
-
Form 8-K Eos Energy Enterprises, For: Sep 10
-
Form D Alexander Capital Ventur
-
Form DEFA14A TWIN DISC INC
-
Form 425 Onconetix, Inc. Filed by: Onconetix, Inc.
-
Form 8-K PennyMac Financial Servi For: Sep 14
-
Form 8-K Bionano Genomics, Inc. For: Sep 14
-
Form DEF 14A TWIN DISC INC For: Oct 29
-
Form 8-K Rimini Street, Inc. For: Sep 14
-
Form 4 Definium Therapeutics, For: Sep 14 Filed by: Roberts Brandi
-
Form 4 Definium Therapeutics, For: Sep 14 Filed by: Karlin Daniel
-
Form 4 Definium Therapeutics, For: Sep 14 Filed by: Barrow Robert
-
Form 8-K GRACO INC For: Sep 11
-
Form 4 Definium Therapeutics, For: Sep 14 Filed by: Wiley Matthew T.
-
Form 4 Definium Therapeutics, For: Sep 14 Filed by: Sullivan Mark
-
Form 6-K BioNTech SE For: Sep 14
-
Form D SP-0821 Fund I, a series
-
Form 10-Q Somitos Corp. For: Aug 31
-
Form 6-K Mobilicom Ltd For: Sep 14
-
Form 8-K ENBRIDGE INC For: Sep 14
-
Form 25-NSE Shell plc Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form D Alexander Capital Ventur
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form FWP Amerant Bancorp Inc. Filed by: Amerant Bancorp Inc.
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form DEFM14A Integer Holdings Corp
-
Form 25-NSE Shell International Fina Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form D VI-0727 Fund I, a series
-
Form 25-NSE Banco Santander, S.A. Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form D VO-0813 Fund I, a series

